A tablet comprising the following components (A) and (B): (A) a granule comprising a pharmaceutically active ingredient selected from 2 - [[6- [(3R) -3-amino-1-piperidinyl] - 3,4-dihydro-3-methyl-2,4-dioxo-1 (2H) -pyrimidinyl] methyl] -benzonitrile and a salt of 2- [[6 - [(3R) -3-amino-1-piperidinyl] -3,4-dihydro-3-methyl-2,4-dioxo-1 (2H) -pyrimidinyl] methyl] -benzonitrile, and microcrystalline cellulose； (B) a tablet manufacturing aid comprising magnesium stearate and microcrystalline cellulose.Un comprimido que comprende los siguientes componentes (A) y (B): (A) un gránulo que comprende un ingrediente activo farmacéuticamente seleccionado a partir del 2-[[6- [(3R)-3-amino-1-piperidinil]-3,4-dihidro-3-metil-2,4-dioxo-1(2H)-pirimidinil]metil]-benzonitrilo y una sal del 2- [[6-[(3R)-3-amino-1-piperidinil]-3,4-dihidro-3-metil-2,4-dioxo-1(2H)-pirimidinil]metil]-benzonitrilo, y celulosa microcristalina； (B) un auxiliar de la fabricación del comprimido que comprende estearato de magnesio y celulosa microcristalina.
